Solid Biosciences (SLDB) Amortizatization of Intangibles (2017 - 2026)
Solid Biosciences' (SLDB) quarterly Amortizatization of Intangibles came in at $619000.0 in Q1 2026, up 98.4% year-on-year from $312000.0 in Q1 2025, and down 17.14% quarter-over-quarter from $747000.0 in Q4 2025.
Solid Biosciences (SLDB) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends
Solid Biosciences has disclosed Amortizatization of Intangibles across 10 years of filings, most recently posting $619000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $619000.0, up 98.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 35.17% YoY), and the FY2025 annual result was $1.9 million, down 47.83% from the prior year.
- Amortizatization of Intangibles came in at $619000.0 for Q1 2026 at Solid Biosciences, down from $747000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q3 2024 to a low of -$371000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $488000.0 (2025), against an average of $485882.4.
- Across the five-year window, Amortizatization of Intangibles jumped 5688.24% in 2023 and sank 72.93% in 2025, its largest moves.
- Solid Biosciences' Amortizatization of Intangibles stood at $276000.0 in 2022, then jumped by 317.03% to $1.2 million in 2023, then sank by 30.23% to $803000.0 in 2024, then retreated by 6.97% to $747000.0 in 2025, then declined by 17.14% to $619000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $619000.0 (Q1 2026), $747000.0 (Q4 2025), and $327000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - | 619,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 619,000.00 |
| Mar 31, 2026 | 619,000.00 |
| Dec 31, 2025 | 747,000.00 |
| Dec 31, 2025 | 747,000.00 |
| Sep 30, 2025 | 327,000.00 |
| Sep 30, 2025 | 327,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Mar 31, 2025 | 312,000.00 |
| Mar 31, 2025 | 312,000.00 |
| Dec 31, 2024 | 803,000.00 |
| Dec 31, 2024 | 803,000.00 |
| Sep 30, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 540,000.00 |
| Mar 31, 2024 | 540,000.00 |
| Dec 31, 2023 | 1.15 Mn |
| Dec 31, 2023 | 1.15 Mn |